- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06333184
Smoothies and Blood Sugars
September 12, 2024 updated by: Javier Gonzalez, University of Bath
Examining the Blood Sugar Response to Fruit Smoothie Consumption
Glycaemic responses to fruit smoothies may depend on the food matrix (e.g., degree of processing and physical structure), ingestion rate, dose ingested and fibre content.
Furthermore, the method of sampling could alter inferences.
The aim of this project is to characterise how these factors affect the glycaemic response to a commercially available fruit smoothie.
Participants will ingest 7 different test drinks in a randomised, crossover design with fingerstick capillary blood sampling alongside continuous glucose monitors.
Test drinks will include a glucose reference (CONTROL), the commercial product matched for carbohydrate to CONTROL (PRODUCT), equivalent carbohydrate ingested as whole fruits (WHOLE), equivalent carbohydrate ingested as blended fruits (WHOLE), equivalent carbohydrate as the commercial product ingested slowly (SLOW), equivalent carbohydrate as the commercial product ingested with additional fibre (FIBRE), and the commercial product ingested in a dose typically bought (DOSE).
These data will provide insight into how the food matrix and different patterns of ingestion can alter the glycaemic response to a fruit smoothie, and how the measurement method may alter interpretations.
Study Overview
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bath, United Kingdom, BA2 7AY
- Department for Health, University of Bath
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age: 18-65 years
- Body mass index 18-30 kg/m2
Exclusion Criteria:
- diagnosis of any form of diabetes
- intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
- Fructose malabsorption
- Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
- pregnant or lactating
- any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
50 g glucose (55 g dextrose powder accounting for hydration) plus 417 mL water
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Product
417 mL of commercially available "Mango & Passion fruit" fruit smoothie providing 50 g carbohydrate
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Whole
Apples (51%), Mango (16%), Banana (16%), Orange (12%), Passionfruit (3%), Peach (2%), Lime (0.4%; recipe matched to PRODUCT) eaten as whole fruit with added water as needed to match volume.
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Blend
Apples (51%), Mango (16%), Banana (16%), Orange (12%), Passionfruit (3%), Peach (2%), Lime (0.4%; recipe matched to PRODUCT) eaten as blended fruit with added water as needed to match volume.
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Slow
417 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 50 g carbohydrate ingested slowly over 25-35 mins.
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Fibre
417 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 50 g carbohydrate with 6 g of added inulin.
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
|
Experimental: Dose
250 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 30 g carbohydrate.
|
Fruit ingested in whole form or as either commercially available, or home-made smoothies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycaemic index of product with capillary vs CGM
Time Frame: 120 min
|
The difference in glycaemic index [2-hour incremental area under the curve (mmol/L-1x120 min) for PRODUCT relative to CONTROL expressed as a percentage] in capillary blood samples versus continuous glucose monitors.
|
120 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycaemic index of all conditions with capillary vs CGM
Time Frame: 120 min
|
The difference in glycaemic index [2-hour incremental area under the curve (mmol/L-1x120 min) for all other conditions (WHOLE, BLEND, SLOW, FIBRE, DOSE) relative to CONTROL expressed as a percentage] in capillary blood samples versus continuous glucose monitors.
|
120 min
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Condition-by-sampling interaction
Time Frame: 120 min
|
The effect of condition-by-blood sampling (capillary vs continuous glucose monitor) interaction for the 2-hour incremental area under the curve for all conditions.
|
120 min
|
|
GI of products in capillary samples
Time Frame: 120 min
|
Comparisons between conditions for the 2-hour incremental area under the curve relative to CONTROL using capillary blood glucose.
|
120 min
|
|
GI of products in continuous glucose monitors
Time Frame: 120 min
|
Comparisons between conditions for the 2-hour incremental area under the curve relative to CONTROL using continuous glucose monitors.
|
120 min
|
|
Peak glucose capillary vs CGM
Time Frame: 120 min
|
The condition-by-blood sampling interaction for the postprandial peak glucose concentrations (mmol/L)
|
120 min
|
|
Time to peak glucose capillary vs CGM
Time Frame: 120 min
|
The condition-by-blood sampling interaction for the time to peak glucose concentrations (min)
|
120 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2024
Primary Completion (Actual)
August 30, 2024
Study Completion (Actual)
August 30, 2024
Study Registration Dates
First Submitted
March 20, 2024
First Submitted That Met QC Criteria
March 20, 2024
First Posted (Actual)
March 27, 2024
Study Record Updates
Last Update Posted (Actual)
September 19, 2024
Last Update Submitted That Met QC Criteria
September 12, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 3085-4215
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified data will be made available open access on the University of Bath Research Data Archive (RDA) at the point of publication in a peer-reviewed journal.
IPD Sharing Time Frame
These will become available at the point of publication permanently.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Disturbance
-
The Swedish School of Sport and Health SciencesActive, not recruiting
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Appalachian State UniversityAGRANACompletedMetabolic Disturbance | Permeability; IncreasedUnited States
-
Northumbria UniversityCompletedMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
Appalachian State UniversityCompletedGastrointestinal Dysfunction | Metabolic DisturbanceUnited States
-
University of TorontoWomen's College HospitalCompleted
-
University of TorontoCanadian Institutes of Health Research (CIHR)RecruitingSedentary Behavior | Metabolic DisturbanceCanada
-
University of TorontoCompletedMetabolic DisturbanceCanada
-
Northumbria UniversityUnknownMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
University of NottinghamCompletedObesity | Metabolic DisturbanceUnited Kingdom
Clinical Trials on Food
-
Mount Saint Vincent UniversityCompletedBlood Glucose | Eating | Food | AppetiteCanada
-
NYU Langone HealthNational Cancer Institute (NCI); New York University; National Institutes of...RecruitingCalorie ConsumptionUnited States
-
Mount Saint Vincent UniversityCompletedEating | Food | AppetiteCanada
-
Mount Saint Vincent UniversityCompletedEating | Satiety | Food | Physical ComfortCanada
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes MellitusSingapore
-
National Institute of Diabetes and Digestive and...CompletedObesity | Healthy DietUnited States
-
NYU Langone HealthRecruitingCalorie ConsumptionUnited States
-
PepsiCo Global R&DNot yet recruiting
-
CargillCompleted